pH-Dependent Solubility and Dissolution Behavior of Carvedilol-Case Example of a Weakly Basic BCS Class II Drug
被引:144
作者:
Hamed, Rania
论文数: 0引用数: 0
h-index: 0
机构:
Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Hamed, Rania
[1
]
Awadallah, Areeg
论文数: 0引用数: 0
h-index: 0
机构:
Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Awadallah, Areeg
[1
]
Sunoqrot, Suhair
论文数: 0引用数: 0
h-index: 0
机构:
Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Sunoqrot, Suhair
[1
]
论文数: 引用数:
h-index:
机构:
Tarawneh, Ola
[1
]
Nazzal, Sami
论文数: 0引用数: 0
h-index: 0
机构:
Univ Louisiana Monroe, Sch Pharm, Coll Hlth & Pharmaceut Sci, Monroe, LA 71201 USAAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Nazzal, Sami
[2
]
AlBaraghthi, Tamadur
论文数: 0引用数: 0
h-index: 0
机构:
Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
AlBaraghthi, Tamadur
[1
]
Al Sayyad, Jihan
论文数: 0引用数: 0
h-index: 0
机构:
Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Al Sayyad, Jihan
[1
]
Abbas, Aiman
论文数: 0引用数: 0
h-index: 0
机构:
Hikma Pharmaceut, POB 182400Amman, Amman 11118, JordanAl Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
Abbas, Aiman
[3
]
机构:
[1] Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
[2] Univ Louisiana Monroe, Sch Pharm, Coll Hlth & Pharmaceut Sci, Monroe, LA 71201 USA
[3] Hikma Pharmaceut, POB 182400Amman, Amman 11118, Jordan
The objective of this study was to investigate the pH-dependent solubility and dissolution of weakly basic Biopharmaceutical Classification Systems (BCS) class II drugs, characterized by low solubility and high permeability, using carvedilol, a weak base with a pK (a) value of 7.8, as a model drug. A series of solubility and in vitro dissolution studies was carried out using media that simulate the gastric and intestinal fluids and cover the physiological pH range of the GI from 1.2 to 7.8. The effect of ionic strength, buffer capacity, and buffer species of the dissolution media on the solubility and dissolution behavior of carvedilol was also investigated. The study revealed that carvedilol exhibited a typical weak base pH-dependent solubility profile with a high solubility at low pH (545.1-2591.4 mu g/mL within the pH range 1.2-5.0) and low solubility at high pH (5.8-51.9 mu g/mL within the pH range 6.5-7.8). The dissolution behavior of carvedilol was consistent with the solubility results, where carvedilol release was complete (95.8-98.2% released within 60 min) in media simulating the gastric fluid (pH 1.2-5.0) and relatively low (15.9-86.2% released within 240 min) in media simulating the intestinal fluid (pH 6.5-7.8). It was found that the buffer species of the dissolution media may influence the solubility and consequently the percentage of carvedilol released by forming carvedilol salts of varying solubilities. Carvedilol solubility and dissolution decreased with increasing ionic strength, while lowering the buffer capacity resulted in a decrease in carvedilol solubility and dissolution rate.
机构:
Pfizer PGRD, Drug Product Design, Sandwich CT13 9NJ, Kent, EnglandUppsala Univ, Biomed Ctr, Dept Pharm, SE-75123 Uppsala, Sweden
McAllister, Mark
;
Muenster, Uwe
论文数: 0引用数: 0
h-index: 0
机构:
Bayer Pharma AG, Mat Sci & Early Characterizat, Res Site Wuppertal Aprath, Berlin, GermanyUppsala Univ, Biomed Ctr, Dept Pharm, SE-75123 Uppsala, Sweden
机构:
Pfizer PGRD, Drug Product Design, Sandwich CT13 9NJ, Kent, EnglandUppsala Univ, Biomed Ctr, Dept Pharm, SE-75123 Uppsala, Sweden
McAllister, Mark
;
Muenster, Uwe
论文数: 0引用数: 0
h-index: 0
机构:
Bayer Pharma AG, Mat Sci & Early Characterizat, Res Site Wuppertal Aprath, Berlin, GermanyUppsala Univ, Biomed Ctr, Dept Pharm, SE-75123 Uppsala, Sweden